MCKECHNIE DUNCAN (EVP, Chief Commercial Officer) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/26/2026ACC: 0000875320-26-000022
Officer· EVP, Chief Commercial Officer
Since Mar 2026
+6.80K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
6.80K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.72K
Price / share
—
Trade value
—
% of position
29.2%
1/22/2026
16.14K→20.86K
Common Stock
Direct
Shares
+2.08K
Price / share
—
Trade value
—
% of position
10.0%
1/22/2026
20.86K→22.94K
Total
Net shares
+6.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | A · Award | +4.72K | — | — | 29.2% | 16.14K | 20.86K |
| Common Stock Direct | 1/22/2026 | A · Award | +2.08K | — | — | 10.0% | 20.86K | 22.94K |
| Total | +6.80K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported